Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,040 | 7,910 | 8,460 | 12,400 | 2,500 |
| Marketable Securities | 24,160 | 24,060 | 26,240 | 21,510 | 21,300 |
| Receivables | 40 | 60 | 40 | 40 | 40 |
| Other current assets | 960 | 760 | 430 | 260 | 410 |
| TOTAL | $29,200 | $32,790 | $35,170 | $34,210 | $24,250 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 10 | 10 |
| TOTAL | $N/A | $N/A | $N/A | $10 | $10 |
| Total Assets | $34,530 | $38,080 | $40,510 | $39,480 | $29,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,420 | 1,540 | 1,260 | 940 | 1,370 |
| TOTAL | $1,420 | $1,540 | $1,260 | $940 | $1,370 |
| Non-Current Liabilities | |||||
| Long Term Debt | 150 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 150 | 150 | 150 | 150 |
| TOTAL | $150 | $150 | $150 | $150 | $150 |
| Total Liabilities | $1,570 | $1,690 | $1,410 | $1,100 | $1,520 |
| Shareholders' Equity | |||||
| Common Shares | 70,820 | 70,740 | 70,040 | 66,640 | 55,240 |
| Retained earnings | -46,790 | -43,280 | -40,320 | -37,950 | -33,950 |
| Other shareholders' equity | 2,550 | 2,550 | 3,020 | 3,350 | 2,190 |
| TOTAL | $32,950 | $36,380 | $39,100 | $38,380 | $27,940 |
| Total Liabilities And Equity | $34,520 | $38,070 | $40,510 | $39,480 | $29,460 |